Europe – 13 Fully Funded PhD Positions in Biomedicine at IGNITION Doctoral Network

University: IGNITION Doctoral Network (Marie Skłodowska‑Curie Actions, multiple European institutions)

Country: Multiple European countries

Deadline: 2026‑04‑01

Fields: Biomedicine, Neuroscience, Immunology, Molecular Biology, Medical Sciences

Topic: Europe – 13 Fully Funded PhD Positions in Biomedicine at IGNITION Doctoral Network

Position: PhD; Real Country: Multiple European countries; Main Category: life & medical sciences

About The University Or Research Institute

The IGNITION Doctoral Network is a prestigious consortium funded by the European Union under the Marie Skłodowska‑Curie Actions (MSCA) framework. This ambitious program unites ten leading European research institutions, each renowned for excellence in biomedical research and doctoral training. As part of the Horizon Europe initiative, the network provides doctoral candidates with unparalleled access to state‑of‑the‑art facilities, mentorship from distinguished scientists, and a vibrant, collaborative academic environment.

The IGNITION network’s institutions are strategically located across Europe, offering students a unique opportunity to experience diverse cultures, research methodologies, and scientific perspectives. This transnational approach not only enhances scientific discovery but also fosters the development of well‑rounded, globally minded researchers.

Europe itself is a hub for scientific innovation and academic excellence, with a long‑standing tradition of fostering international collaboration. Doctoral students benefit from a high standard of living, robust support systems, and the ability to travel and network across borders. The MSCA Doctoral Network is particularly known for its commitment to researcher mobility, professional development, and open, transparent recruitment processes.

Research Topic and Significance

The central focus of the IGNITION Doctoral Programme is the comprehensive investigation of Anti‑IgLON5 disease, a rare and enigmatic neurological disorder. Anti‑IgLON5 disease is characterized by a complex interplay between neurodegeneration and autoimmunity, making it a compelling subject for interdisciplinary research.

Understanding this disease is crucial for several reasons. First, it represents a frontier in neuroimmunology, where insights could lead to breakthroughs in diagnostics, treatment, and prevention not only for Anti‑IgLON5 but also for other related neurological conditions. Second, the disease exemplifies the challenges of rare disorders, where limited knowledge and resources necessitate robust international collaboration. By tackling these challenges, the IGNITION network aims to advance both scientific knowledge and clinical practice, ultimately improving patient outcomes and public health.

The significance of this research extends beyond academia. It contributes to the broader societal goal of combating neurological disorders, a growing concern in aging populations worldwide. The IGNITION programme’s interdisciplinary and multinational approach ensures research findings have wide‑reaching impact, setting new standards in the diagnosis and management of neuroimmunological diseases.

Project Details

The IGNITION Doctoral Network offers 13 fully funded PhD positions, each embedded within one of the ten partner institutions across Europe. Candidates will have the flexibility to select up to three preferred projects from a diverse portfolio, ensuring alignment with their academic interests and career aspirations.

Each project is designed to address a specific aspect of Anti‑IgLON5 disease, encompassing areas such as molecular mechanisms, immunopathology, clinical phenotyping, biomarker discovery, and therapeutic development. The network emphasizes a transnational and interdisciplinary training model, with doctoral candidates expected to engage in collaborative research, participate in joint training activities, and benefit from secondments to other partner institutions.

The IGNITION programme is committed to open, transparent, and merit‑based recruitment, ensuring equal opportunity and fostering a diverse cohort of researchers. The selection process includes eligibility checks, scientific evaluation, and an oral interview to assess motivation and fit with the program’s objectives.

Candidate Profile

The ideal candidates for the IGNITION Doctoral Programme are highly motivated, ambitious early‑career researchers with a strong academic background in biomedicine or related disciplines. Suitable fields of study include, but are not limited to:

• Biomedicine
• Neuroscience
• Immunology
• Molecular Biology
• Medical Sciences

Applicants should possess a university degree and a master’s (or equivalent) that together comprise at least 300 ECTS credits (for those educated within the European Higher Education Area). For candidates from outside Europe, qualifications must allow access to doctoral studies in the country of issue, and all documentation must be legalized and officially translated to English if applicable.

A proficient command of English is essential, as the program and all communications are conducted in English. Candidates should demonstrate a passion for biomedical research, the ability to work collaboratively in international teams, and a commitment to advancing knowledge in neuroimmunology.

Key Attributes Include

• Strong analytical and problem‑solving skills
• Excellent written and oral communication abilities
• Adaptability and willingness to engage in cross‑border research
• A proactive and self‑driven approach to learning

Applicants must not already possess a doctoral degree and must comply with the MSCA mobility rule, which requires that they have not resided or carried out their main activity (work or studies) in the host country for more than 12 months in the 36 months preceding the application deadline.

Application Process

The IGNITION Doctoral Programme has a clear and structured application process:

• Deadline for applications: 2026‑04‑01
• All applications must be submitted through the online application tool, with proposals written in English.
• After submitting the online form, an automatic PDF will be generated and sent to the applicant’s email.
• To finalize the application, this PDF must be sent to the IGNITION Project Manager, accompanied by academic records (proof of degree and credits for EHEA candidates or equivalent documentation for non‑EHEA candidates), an English language certificate (if available), and two reference letters from different referees, ideally certified and electronically signed, including referee contact details.

For further details on eligibility and the application process, candidates are encouraged to consult the Guide for Applicants available on the IGNITION website. The start date for successful candidates will be agreed upon with the research group and the host institution, with expected commencement between June and September 2026.

Application Link

To complete the application, this document must be sent to the IGNITION Project Manager at , together with the following additional information:

• Academic records (at least 300 ECTS credits for EHEA candidates or equivalent for non‑EHEA candidates)
• English certificate, if available
• Two reference letters

Selection Process

The evaluation process follows open, transparent, and merit‑based recruitment criteria. The selection procedure consists of the following stages:

• Eligibility Check – determines whether the candidate meets all the eligibility criteria required for the program.
• Evaluation Phase – best eligible candidates are selected based on excellence, considering their academic background, achievements, and overall potential.
• Oral Online Interview – shortlisted candidates will participate in an online interview, where their scientific knowledge, motivation, and alignment with the IGNITION program will be assessed.
• Start of the Fellowship – the exact starting date of the fellowship will be agreed upon with the research group and IDIBAPS once the fellowship has been awarded.

Conclusion

The IGNITION Doctoral Programme represents a unique and prestigious opportunity for aspiring biomedical researchers to launch their careers within a world‑class, collaborative research network. By joining this program, you will not only advance your own expertise but also contribute to a critical area of medical science with the potential for significant societal impact.

If you are ready to challenge yourself, expand your horizons, and make a meaningful contribution to neuroimmunological research, we strongly encourage you to apply. Stay connected for similar opportunities and continue exploring ways to shape your future in science.

Questions & Answers

Question: What is the main focus of the IGNITION Doctoral Programme?Answer: The program is dedicated to understanding Anti‑IgLON5 disease through interdisciplinary research across multiple European institutions.

Question: Who is eligible to apply for these PhD positions?Answer: Applicants must not already possess a PhD, must fulfill the MSCA mobility rule, and must have academic qualifications that grant access to doctoral studies in Europe.

Question: What documents are required for the application?Answer: Required documents include academic records, proof of English proficiency (if available), and two reference letters with referee contact details.

Question: Is proficiency in English mandatory?Answer: Yes, a good command of English is required, as the program is conducted entirely in English.

Question: Can candidates from outside Europe apply?Answer: Yes, candidates from non‑European countries are eligible, provided their qualifications allow access to doctoral studies in their country of issue, and all documentation is properly legalized and translated.

Question: How many projects can I apply to?Answer: Applicants can select up to three preferred projects from the 13 available.

Question: Where can I find more information about the program and projects?Answer: Detailed information, including project descriptions and eligibility criteria, is available on the IGNITION website and in the Guide for Applicants.

Question: What is the deadline for applications?Answer: The application deadline is April 1, 2026.

Question: What is the selection process?Answer: The process involves eligibility checks, scientific evaluation, and an oral interview to assess the candidate’s fit with the program.

Also See

• Germany – Research Group Leader in Systems Immunology at Friedrich‑Loeffler‑Institut
• Switzerland – PhD in Neuroimmunology at University of Basel
• USA – Postdoctoral Fellowship in Translational Neuroscience at Boston Children’s Hospital
• Germany – PhD in Immune‑Neuro‑Behavioral Interactions at Heinrich Heine University Düsseldorf
• Germany – PhD in Translational Protein Biochemistry at University of Ulm